Has Okanta Jackson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,410 in general payments to Okanta Jackson, MD across 70 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Okanta Jackson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Okanta Jackson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Okanta Jackson, MD

Dermatology · Tallahassee, FLNPI 1578670055

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Novartis at 25.4% of the total. 2025 is the largest year on record at $459, 2.4 times the $191 reported in 2019. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.

$1,410in general payments, 2019–2025

Across 70 payments — averaging $20.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$358
AbbVie$266
Lilly USA, LLC$124
LEO Pharma Inc.$105
Johnson & Johnson$100
UCB, Inc.$79
plus $377 from 12 others

What the payments were for

Food & beverage$1,39399%
Education$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	22	$358
AbbVie(2 entities)	6	$266
Lilly USA, LLC	7	$124
LEO Pharma Inc.	5	$105
Johnson & Johnson	6	$100
UCB, Inc.	4	$79
Regeneron Healthcare Solutions, Inc.	3	$70
Sun Pharmaceutical Industries Inc.	3	$66
Incyte Corporation	2	$34
Biofrontera Inc.	2	$33
Pfizer	2	$31
Amgen	1	$26
VYNE Pharmaceuticals Inc.	1	$24
Strata Skin Sciences, Inc.	2	$23
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$20
Triad Life Sciences Inc.	1	$17
Stemline Therapeutics Inc.	1	$17
Sanofi	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$139
Rinvoq$139

How this compares

$1,410 in reported general payments places this provider in the 35th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$598,198

Medicare patients

546

Services billed

3,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Triamcinolone Acetonide	178	$3,475
Doxycycline Hyclate	113	$2,206
Metronidazole	23	$1,942
Clobetasol Propionate	52	$1,884
Ketoconazole	48	$1,156
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	34	$806
ValacyclovirValacyclovir Hcl	15	$385
Fluconazole	24	$351
Desonide	11	$342
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	63	$290

Paid to pharmacies, not to this prescriber.

Other dermatology in Tallahassee

Marc IngleseTallahassee$989K
Francisco KerdelMiami$2.1M
Brad GlickMargate$2M
Robert KirsnerMiami$1.4M
John MinniStuart$1.4M
Gil YosipovitchMiami$1M
Shino Bay AguileraFt Lauderdale$1M
Robert SnyderPembroke Pines$1M
Jeremy GreenCoral Gables$952K
Mercedes GonzalezMiami$943K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →